These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 1532133)

  • 41. Binding sites for [3H]SCH 23390 in retina: properties and possible relationship to dopamine D1-receptors mediating stimulation of adenylate cyclase.
    Makman MH; Dvorkin B
    Brain Res; 1986 Dec; 387(3):261-70. PubMed ID: 2950967
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Autoradiographic identification of D1 dopamine receptors labelled with [3H]dopamine: distribution, regulation and relationship to coupling.
    Hervé D; Trovero F; Blanc G; Glowinski J; Tassin JP
    Neuroscience; 1992; 46(3):687-700. PubMed ID: 1532052
    [TBL] [Abstract][Full Text] [Related]  

  • 43. D1 and D2 and D3.
    Healy D
    Br J Psychiatry; 1991 Sep; 159():319-24. PubMed ID: 1683592
    [No Abstract]   [Full Text] [Related]  

  • 44. Decreased [(3)H]spiperone binding in the anterior cingulate cortex of schizophrenia patients: an autoradiographic study.
    Zavitsanou K; Huang XF
    Neuroscience; 2002; 109(4):709-16. PubMed ID: 11927153
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Localization of dopamine receptors in the rabbit renal artery: a histoautoradiographic study.
    Alessandrini C; Cavallotti C; De Rossi M; Fruschelli C; Gerli R; Mione MC; Sacchi G; Amenta F
    Pharmacology; 1984; 29(1):17-23. PubMed ID: 6205406
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Critical reevaluation of spiperone and benzamide binding to dopamine D2 receptors: evidence for identical binding sites.
    Malmberg A; Jerning E; Mohell N
    Eur J Pharmacol; 1996 May; 303(1-2):123-8. PubMed ID: 8804920
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Expression of functional D2 dopamine receptors following differentiation of Y-79 human retinoblastoma cells.
    Monsma FJ; Barton AC; Sibley DR
    J Neurochem; 1990 Apr; 54(4):1200-7. PubMed ID: 1968958
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Dopamine D2 receptors selectively labeled by a benzamide neuroleptic: [3H]-YM-09151-2.
    Niznik HB; Grigoriadis DE; Pri-Bar I; Buchman O; Seeman P
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Jun; 329(4):333-43. PubMed ID: 2863760
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Selective labelling of dopamine (D2) receptors in rat striatum by [3H]domperidone but not by [3H]spiperone.
    Lazareno S; Nahorski SR
    Eur J Pharmacol; 1982 Jul; 81(2):273-85. PubMed ID: 7117377
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Reduced binding of 3H-spiroperidol to lymphocyte in Wilson's disease.
    Członkowski A; Członkowska A
    Acta Neurol Scand; 1984 May; 69(5):298-301. PubMed ID: 6464668
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Characterization of binding sites for 3H-spiroperidol in human retina.
    McGonigle P; Wax MB; Molinoff PB
    Invest Ophthalmol Vis Sci; 1988 May; 29(5):687-94. PubMed ID: 2452802
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Properties of D2 dopamine receptor autoradiography: high percentage of high-affinity agonist sites and increased nucleotide sensitivity in tissue sections.
    Richfield EK; Young AB; Penney JB
    Brain Res; 1986 Sep; 383(1-2):121-8. PubMed ID: 3768686
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dopamine D2 receptor binding in adrenal medulla: characterization using [3H]spiperone.
    Quik M; Bergeron L; Mount H; Philie J
    Biochem Pharmacol; 1987 Nov; 36(21):3707-13. PubMed ID: 2960326
    [TBL] [Abstract][Full Text] [Related]  

  • 54. 3H-spiperone binding in platelet membranes: a possible biological marker for schizophrenia.
    Sethi BB; Kumar P; Agarwal AK; Seth PK; Trivedi JK
    Acta Psychiatr Scand; 1986 Feb; 73(2):186-90. PubMed ID: 3705995
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Reduced dopaminergic binding during aging in the rodent striatum.
    Severson JA; Finch CE
    Brain Res; 1980 Jun; 192(1):147-62. PubMed ID: 6155174
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Trapping of labelled ligands in intact cells: a pitfall in binding studies.
    Maloteaux JM; Gossuin A; Waterkeyn C; Laduron PM
    Biochem Pharmacol; 1983 Sep; 32(17):2543-8. PubMed ID: 6615549
    [TBL] [Abstract][Full Text] [Related]  

  • 57. D2 dopamine receptors on bovine chromaffin cell membranes: identification and characterization by [3H]N-methylspiperone binding.
    Lyon RA; Titeler M; Bigornia L; Schneider AS
    J Neurochem; 1987 Feb; 48(2):631-5. PubMed ID: 3794725
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Species variation in dopamine receptor binding.
    Creese I; Stewart K; Snyder SH
    Eur J Pharmacol; 1979 Nov; 60(1):55-66. PubMed ID: 520417
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Characterization of dopamine D2 receptors in the pituitary of the African catfish, Clarias gariepinus.
    Van Asselt LA; Goos HJ; De Leeuw R; Peter RE; Hol EM; Wassenberg FP; Van Oordt PG
    Gen Comp Endocrinol; 1990 Oct; 80(1):107-15. PubMed ID: 2148730
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Schizophrenia: D4 receptor elevation. What does it mean?
    Seeman MV
    J Psychiatry Neurosci; 1994 May; 19(3):171-6. PubMed ID: 7913338
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.